Next Tactic in Battle to Lower Drug Prices: Litigation?

, Corporate Counsel

   | 2 Comments

Walgreens and CVS, two retail pharmacy giants, are being sued in two separate class action lawsuits filed earlier this week. They are accused of colluding with pharmacy benefit managers to sell generic drugs at a higher cost if they're bought with insurance rather than cash.

This premium content is reserved for CC Corporate Counsel subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

  • Michael Smith

    Yes, I‘m sure the American Tort Reform Association knows what‘s best for consumers. Let‘s allow the unregulated gouging to continue.

  • Darren McKinney, American Tort Reform Association, Washington, D.C.

    Does anyone honestly believe that these lawsuits will do anything more than raise prices for all consumers (as litigation costs are invariably passed on) and enrich the self-interested class-action lawyers who‘ve orchestrated them?

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202795329523

Thank you!

This article's comments will be reviewed.